- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Big Green Snowflakes
Hong Kong Pharmaceuticals & Biotech Big Green Snowflakes
Results
114
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
114 companies
InnoCare Pharma
Market Cap: HK$34.9b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$17.70
7D
4.7%
1Y
242.4%
Uni-Bio Science Group
Market Cap: HK$985.3m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.17
7D
4.4%
1Y
139.1%
CanSino Biologics
Market Cap: HK$17.3b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$51.90
7D
6.2%
1Y
179.3%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$119.8b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$524.00
7D
15.4%
1Y
209.0%
CARsgen Therapeutics Holdings
Market Cap: HK$12.7b
An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.
2171
HK$22.94
7D
-0.7%
1Y
752.8%
Hansoh Pharmaceutical Group
Market Cap: HK$224.7b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$37.12
7D
3.1%
1Y
86.7%
RemeGen
Market Cap: HK$54.3b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.
9995
HK$92.45
7D
-5.8%
1Y
642.0%
Everest Medicines
Market Cap: HK$21.3b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$60.65
7D
-4.6%
1Y
158.1%
Akeso
Market Cap: HK$142.5b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$154.70
7D
-0.6%
1Y
221.0%
China Traditional Chinese Medicine Holdings
Market Cap: HK$10.9b
China Traditional Chinese Medicine Holdings Co.
570
HK$2.16
7D
-1.4%
1Y
-50.3%
Sanai Health Industry Group
Market Cap: HK$67.3m
An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
1889
HK$0.44
7D
0%
1Y
91.3%
Shanghai Junshi Biosciences
Market Cap: HK$49.1b
A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.
1877
HK$34.50
7D
11.4%
1Y
222.4%
Shenzhen Neptunus Interlong Bio-technique
Market Cap: HK$268.5m
Engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China.
8329
HK$0.16
7D
1.9%
1Y
25.0%
Laekna
Market Cap: HK$6.5b
An investing holding company, engages in the discovering, development, and commercialization of therapies for patients with cancer, metabolic diseases, and liver fibrosis in the People’s Republic of China, the United States of America, and South Korea.
2105
HK$17.05
7D
4.3%
1Y
251.5%
CStone Pharmaceuticals
Market Cap: HK$18.0b
A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally.
2616
HK$12.33
7D
14.6%
1Y
722.0%
Beijing Luzhu Biotechnology
Market Cap: HK$4.8b
A biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China.
2480
HK$24.04
7D
-2.4%
1Y
11.8%
Viva Biotech Holdings
Market Cap: HK$5.9b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$2.80
7D
5.3%
1Y
382.8%
Shandong Boan Biotechnology
Market Cap: HK$8.3b
A biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China.
6955
HK$13.31
7D
-4.1%
1Y
45.1%
Wai Yuen Tong Medicine Holdings
Market Cap: HK$393.8m
An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
897
HK$0.35
7D
9.4%
1Y
78.6%
Abbisko Cayman
Market Cap: HK$12.2b
Engages in the research and development of pharmaceutical products in the People’s Republic of China and the European Union.
2256
HK$18.21
7D
6.4%
1Y
474.4%
China Health Group
Market Cap: HK$170.2m
An investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China.
8225
HK$0.17
7D
-7.1%
1Y
90.0%
Ascentage Pharma Group International
Market Cap: HK$29.1b
A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.
6855
HK$79.35
7D
-4.6%
1Y
142.3%
Transcenta Holding
Market Cap: HK$2.0b
A clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs for unmet medical needs in the People’s Republic of China and the United States.
6628
HK$4.83
7D
47.3%
1Y
263.2%
Frontage Holdings
Market Cap: HK$2.8b
A contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies.
1521
HK$1.40
7D
-2.8%
1Y
154.5%
Duality Biotherapeutics
Market Cap: HK$32.0b
A clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.
9606
HK$363.20
7D
15.1%
1Y
n/a
VISEN Pharmaceuticals
Market Cap: HK$4.7b
An investment holding company, engages in the development and commercialization of paradigm-shifting endocrine therapies in the Chinese Mainland.
2561
HK$45.28
7D
-0.9%
1Y
n/a
Shanghai Henlius Biotech
Market Cap: HK$44.5b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$81.85
7D
5.1%
1Y
253.6%
Antengene
Market Cap: HK$5.0b
A clinical-stage APAC biopharmaceutical company, develops novel oncology therapies in Greater China and internationally.
6996
HK$7.38
7D
15.9%
1Y
969.6%
Hangzhou Jiuyuan Genetic Biopharmaceutical
Market Cap: HK$3.5b
A biopharmaceutical company, engages in the research, development, production, and sale of biopharmaceutical products and medical devices.
2566
HK$14.38
7D
8.1%
1Y
n/a
Nanjing Leads Biolabs
Market Cap: HK$13.1b
A clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide.
9887
HK$65.80
7D
-0.5%
1Y
n/a
Alphamab Oncology
Market Cap: HK$10.0b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biotherapeutics for cancer treatment in the People’s Republic of China.
9966
HK$10.33
7D
11.6%
1Y
353.1%
Keymed Biosciences
Market Cap: HK$23.1b
A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.
2162
HK$78.45
7D
13.4%
1Y
112.6%
Biosino Bio-Technology and Science Incorporation
Market Cap: HK$112.9m
Manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China.
8247
HK$0.78
7D
-24.3%
1Y
20.0%
Extrawell Pharmaceutical Holdings
Market Cap: HK$286.8m
An investment holding company, develops, manufactures, and sell of pharmaceutical products in the People’s Republic of China and Hong Kong.
858
HK$0.12
7D
-0.8%
1Y
224.3%
Genor Biopharma Holdings
Market Cap: HK$2.6b
A biopharmaceutical company, focuses on developing and commercializing oncology and autoimmune drugs in China and internationally.
6998
HK$4.91
7D
14.7%
1Y
245.8%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$10.0b
A biotechnology company, engages in the research and development of novel antibody-based drugs in the People’s Republic of China, the United States, and internationally.
2315
HK$25.02
7D
10.5%
1Y
299.0%